Literature DB >> 34091077

Laurus nobilis ethanolic extract attenuates hyperglycemia and hyperinsulinemia-induced insulin resistance in HepG2 cell line through the reduction of oxidative stress and improvement of mitochondrial biogenesis - Possible implication in pharmacotherapy.

Nabila Bourebaba1, Katarzyna Kornicka-Garbowska1, Krzysztof Marycz1, Lynda Bourebaba2, Anna Kowalczuk3.   

Abstract

The aim of this study was to establish the potential effect of Laurus nobilis ethanolic extract on improving insulin sensitivity and protecting liver cells from apoptosis, mitochondrial dysfunction, oxidative stress (OS), and inflammation; all of which considered as major alterations occurring during insulin resistance (IR) as well as diabetes onset, in hyperinsulinemic and hyperglycemic-induced HepG2 cell line. Thereby, L. nobilis ethanolic extract has been first chemically characterized using LC-MS/MS technique. Subsequently, HepG2 cells were pre-treated with an optimal concentration of L. nobilis ethanolic extract for 24 h, and then, subjected to 30 mM D-glucose and 500 nM insulin mixture for another 24 h in order to induce hyperinsulinemia and hyperglycaemia (HI/HG) status. Several parameters such as biocompatibility, hepatotoxicity, reactive oxygen species (ROS), mitochondrial transmembrane potential, dynamics, and metabolism, multicaspase activity, glucose uptake, in addition to genes and proteins expression levels were investigated. The obtained results showed that the bioactive extract of Laurus nobilis increased the number of living cells and their proliferation rate, significantly attenuated apoptosis by modulating pro-apoptotic pathways (p21, p53 and Bax genes), allowed a relative normalization of caspases-activity, and decreased the expression of inflammatory markers including c-Jun, NF-κB and Tlr4 transcripts. L. Nobilis ethanolic extract reduced considerably total intracellular ROS levels in challenged HepG2 cells, and regulated the mitochondrial OXPHOS pathway, demonstrating the potential antioxidant effect of the plant. Ethanolic plant extract increased insulin sensitivity, since an elevated expression of master transcripts responsible for insulin sensitivity including IRS1, IRS2, INSR was found. Taken together, obtained data suggest that L. nobilis ethanolic extract offers new insights in the development of potential antioxidant, insulin sensitizing as well as hepatoprotective drugs.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hyperglycaemia; Inflammation; Laurus nobilis; Mitochondria; OXPHOS; Oxidative stress

Mesh:

Substances:

Year:  2021        PMID: 34091077     DOI: 10.1016/j.mito.2021.06.003

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  4 in total

1.  Multi-omics study identifies novel signatures of DNA/RNA, amino acid, peptide, and lipid metabolism by simulated diabetes on coronary endothelial cells.

Authors:  Aldo Moreno-Ulloa; Hilda Carolina Delgado-De la Herrán; Carolina Álvarez-Delgado; Omar Mendoza-Porras; Rommel A Carballo-Castañeda; Luis Donis-Maturano; Francisco Villarreal
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Phytochemical Characterization and Evaluation of the Antioxidant and Anti-Enzymatic Activity of Five Common Spices: Focus on Their Essential Oils and Spent Material Extractives.

Authors:  Adriana Trifan; Gokhan Zengin; Mihai Brebu; Krystyna Skalicka-Woźniak; Simon Vlad Luca
Journal:  Plants (Basel)       Date:  2021-12-07

3.  Astaxanthin Carotenoid Modulates Oxidative Stress in Adipose-Derived Stromal Cells Isolated from Equine Metabolic Syndrome Affected Horses by Targeting Mitochondrial Biogenesis.

Authors:  Malwina Mularczyk; Nabila Bourebaba; Krzysztof Marycz; Lynda Bourebaba
Journal:  Biomolecules       Date:  2022-07-27

Review 4.  A Comprehensive Review on Beneficial Effects of Catechins on Secondary Mitochondrial Diseases.

Authors:  Baoyi Chen; Wenting Zhang; Chuyuan Lin; Lingyun Zhang
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.